Observational studyBreast cancer (Tokyo, Japan)2026
Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.
Hiroko Masuda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.